• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Weight loss for infertile-obese women does not increase vaginal birth rates

byDayton McMillanandShaidah Deghan, MSc. MD
May 20, 2016
in Chronic Disease, Obstetrics
Reading Time: 3 mins read
New gene linked to male infertility
Share on FacebookShare on TwitterShare on LinkedIn

1. Women who completed the weight loss program conceived naturally more frequently and were on infertility treatment for a shorter period compared to women in the control group.

2. Obese infertile women placed on a weight loss program for 6 months, followed by 18 months of infertility treatment, did not have higher rates of healthy vaginal births compared to obese infertile women undergoing infertility treatment for 24 months.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Obesity is associated with numerous complications in women’s reproductive health such as anovulation and infertility. Medical infertility treatments have lower success rates, and pregnancy complications such as gestational diabetes and preterm births occur more frequently for obese women compared to non-obese females. Accumulation of this type of evidence has led to guidelines recommending weight loss for obese infertile women looking to conceive, though few large randomized studies have to-date supported this claim.

In line with modern infertility study recommendations, the primary outcome of this trial was vaginal birth of a health single child. Numerous secondary outcomes were measured including changes in participant weight, number of infertility treatments needed to conceive, and method of delivery. Two randomized groups were studied for 24 months: women who began infertility treatment at the beginning of the study (control group) and women participating in a 6 month program aiming with the goal of 5-10% body weight loss followed by 18 months of infertility treatment (intervention group). During the intervention phase participants worked with health coaches and followed nutritional and activity guidelines developed by the National Institutes of Health. At the end of the 24-month study, women in the interventional group conceived naturally at a significantly higher rate and also required less infertility treatment. However, women in the interventional group had significantly lower rates of healthy vaginal deliveries. Adverse events and pregnancy complications were not significantly different between the groups.

Click to read the study, published today in NEJM

RELATED REPORTS

Use of antioxidants does not improve fertility in men trying to conceive

Fresh embryo transfer may yield higher rates of success for women with low prognosis for in vitro fertilization

Relevant Reading: Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis

In-Depth [randomized controlled trial]: From 2009 to 2012 women clinically defined as obese (with a BMI over 29), ages 18 to 39, and considered infertile were enrolled in a randomized trial assessing an intervention focused on weight loss and its impact on infertility and pregnancy outcomes. The study took place in the Netherlands at 23 medical sites. Infertility was defined as World Health Organization (WHO) class 1 or 2 anovulation or being unable to conceive in the previous 12 months despite an intact ovulatory cycle. Exclusionary criteria for the study included having severe endometriosis, premature ovarian failure, an endocrinopathy, being eligible for donor insemination due to partner azoospermia, and those with hypertension or hypertension complications in prior pregnancies. Patients enrolled were assigned in a 1:1 fashion to control or intervention groups (previously described). Infertility treatment involved 6 ovulatory cycles for the intervention group and 12 cycles for the control group of clomiphene citrate. In total, 280 women were followed in the interventional group and 284 in the control group. Women in the intervention group lost significantly more weight than those in the control group (mean of 4.4±5.8 vs. 1.1±4.3 kg, P<0.001). Women in the intervention group had significantly fewer healthy single child vaginal deliveries compared to the control group (27.1% vs. 35.2%, rate ratio in the intervention group 0.77; 95% confidence interval [CI], 0.60 to 0.99). There were no significant inter-group differences in terms of birth rates. There were no significant differences in regards to any of the secondary outcomes. The study was not blinded which limits the study’s generalizability.

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: fertility
Previous Post

Chemotherapy-induced peripheral neuropathy linked to increased fall risk

Next Post

Respiratory symptoms frequent in smokers despite normal spirometry: The SPIROMICS study

RelatedReports

Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Urology

Use of antioxidants does not improve fertility in men trying to conceive

January 13, 2026
Paternal factors associated with short interpregnancy interval
Chronic Disease

Fresh embryo transfer may yield higher rates of success for women with low prognosis for in vitro fertilization

February 3, 2025
Provision of medically-tailored meals linked with lower admissions and medical spending
Chronic Disease

Suboptimal glycemic index management is negatively associated with male fertility

November 10, 2024
American Academy of Pediatrics recommends standards for adverse event disclosures
Cardiology

Poor cardiovascular health is a risk factor for female infertility

July 11, 2024
Next Post
High schoolers use e-cigarettes to vaporize cannabis

Respiratory symptoms frequent in smokers despite normal spirometry: The SPIROMICS study

Lariat device for left atrial appendage exclusion associated with adverse events

Rate and rhythm control similar in atrial fibrillation after cardiac surgery

Pediatric DKA associated with recent acute care visits

Pediatric DKA associated with recent acute care visits

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An electronic health record tool for exercise prescription may reduce fall rate among older adults
  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.